Becton, Dickinson and Co. (BDX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Vincent A. Forlenza
Employees:
76,032
ONE BECTON DR, FRANKLIN LAKES, NJ 07417-1880
2018476800

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorgani® identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Data derived from most recent annual or quarterly report
Market Cap 71.848 Billion Shares Outstanding284.771 Million Avg 30-day Volume 1.274 Million
P/E Ratio42.6171 Dividend Yield1.3361 EPS1.73
Price to Revenue3.5842 Debt to Equity0.7212 EBITDA4.523 Billion
Price to Book Value2.9565 Operating Margin11.9079 Enterprise Value86.797 Billion
Current Ratio1.233 EPS Growth0.114 Quick Ratio0.607
1 Yr BETA 0.2248 52-week High/Low 279.7 / 233.53 Profit Margin8.8619
Operating Cash Flow Growth-13.0993 Altman Z-Score2.3887 Free Cash Flow to Firm 1.808 Billion
Earnings Report2022-08-04
View SEC Filings from BDX instead.

View recent insider trading info

Funds Holding BDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

475 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JONES CHRISTOPHER IAN MONTAGUE

  • Director
8,659 2022-05-06 5

HICKEY DAVID EVP & PRESIDENT, LIFE SCIENCES

  • Officer
3,806 2022-05-06 4

BYINGTON CARRIE L

  • Director
215 2022-05-06 5

NEAL SHANA CAROL CHIEF PEOPLE OFFICER

  • Officer
74 2022-04-06 2

SPOEREL THOMAS J VP CONTROLLER & CHIEF ACCT OFF

  • Officer
1,110 2022-03-01 5

EZELL ANTOINE C EVP, PRESIDENT, NA & CMO

  • Officer
7,325 2022-03-01 2

BROWN WILLIAM M

  • Director
714 2022-02-28 2

LARSON BETTY D EVP HR & CHRO

  • Officer
26,309 2022-02-25 3

CAMPION SIMON D EVP AND SEGMENT PRESIDENT

  • Officer
10,319 2022-02-11 3

FRASER CLAIRE

  • Director
21,556 2022-02-08 4

KHICHI SAMRAT S. EVP AND GENERAL COUNSEL

  • Officer
5,928 2022-02-08 2

CONROY ALEXANDRE EVP OF INTEGRATED SUPPLY CHAIN

  • Officer
23,973 2022-02-03 2

LARSEN MARSHALL O

  • Director
23,806 2022-01-25 1

RING TIMOTHY M

  • Director
80,177 2022-01-25 1

ECKERT R ANDREW

  • Director
6,216 2022-01-25 1

SCOTT BERTRAM L

  • Director
31,860 2022-01-25 1

BURZIK CATHERINE M

  • Director
12,499 2022-01-25 1

HENDERSON JEFFREY WILLIAM

  • Director
3,777 2022-01-25 1

MELCHER DAVID F

  • Director
6,180 2022-01-25 1

POMEROY CLAIRE

  • Director
9,982 2022-01-25 1

REIDY CHRISTOPHER R CFO AND EVP OF ADMINISTRATION

  • Officer
31,524 2021-11-26 1

LIM JAMES C EXECUTIVE VICE PRESIDENT

  • Officer
21,462 2021-11-26 3

POLEN THOMAS E JR EXECUTIVE VICE PRESIDENT

  • Officer
104,510 2021-11-26 1

MAS RIBO ALBERTO EVP AND PRES, LIFE SCIENCES

  • Officer
30,445 2021-11-26 1

GOETTE ROLAND EVP AND PRESIDENT, EMEA

  • Officer
17,931 2021-11-26 2

DELOREFICE CHRISTOPHER EVP & CFO

  • Officer
25,605 2021-11-26 3

RIMEL REBECCA W

  • Director
10,618 2021-09-08 5

FORLENZA VINCENT A CHAIRMAN OF THE BOARD

  • Officer
  • Director
234,660 2020-12-15 0

KALTENBACH PATRICK EVP & PRES LIFE SCIENCES

  • Officer
0 2020-11-26 0

BANERJEE RANJEET PRESIDENT, US REGION & CANADA

  • Officer
4,492 2020-03-30 0

BODNER CHARLES R SVP CORP FIN CHIEF ACCT OFFICE

  • Officer
2,104 2019-09-06 0

BORZI JAMES W EVP & CHIEF SUPPLY CHAIN OFFCR

  • Officer
2,901 2018-11-30 0

OVERLOCK WILARD J JR

  • Director
0 2018-11-06 0

MECKLENBURG GARY A

  • Director
0 2018-11-06 0

TOZZI WILLIAM A EVP PRES INTERVENTIONAL

  • Officer
12,830 2018-07-02 0

SHABSHAB NABIL EXECUTIVE VICE PRESIDENT

  • Officer
7,811 2018-05-11 0

GALLAGHER JOHN E VP, CORP FINANCE AND TREASURER

  • Officer
1,975 2018-03-02 0

THARBY LINDA M EXECUTIVE VICE PRESIDENT

  • Officer
15,088 2018-02-01 0

GROETELAARS JOHN P EVP

  • Officer
42,508 2018-01-02 0

STRAHLMAN ELLEN R SENIOR VICE PRESIDENT

  • Officer
11,714 2017-11-25 0

COHEN GARY M EXECUTIVE VICE PRESIDENT

  • Officer
93,401 2017-09-11 0

SICHAK STEPHEN EXECUTIVE VICE PRESIDENT

  • Officer
7,953 2017-09-08 0

SHERMAN JEFFREY S SR. VP AND GENERAL COUNSEL

  • Officer
22,474 2017-05-25 0

ANDERSON BASIL

  • Director
24,148 2017-01-24 0

ORR JAMES F

  • Director
24,257 2017-01-24 0

HURWITZ JEROME V EXECUTIVE VICE PRESIDENT

  • Officer
3,027 2016-05-06 0

KOZY WILLIAM A EXECUTIVE VICE PRESIDENT

  • Officer
125,172 2015-12-09 0

BECTON HENRY P JR

  • Director
0 2015-11-03 0

DEGRAAN EDWARD

  • Director
22,416 2015-01-27 0

MERCURIO JOSEPH VP AND CORPORATE CONTROLLER

  • Officer
1,932 2014-11-25 0

SOMMER ALFRED

  • Director
20,689 2014-01-28 0

BOLES DONNA M SENIOR VP - HUMAN RESOURCES

  • Officer
16,701 2013-05-17 0

MAHMOUD ADEL

  • Director
13,746 2013-01-29 0

RHODES WILLIAM E. SENIOR VICE PRESIDENT

  • Officer
7,289 2012-11-20 0

UPADHYAY SUKETU SENIOR VP AND CONTROLLER

  • Officer
3,568 2012-11-20 0

ELKINS DAVID V EXECUTIVE VP AND CFO

  • Officer
No longer subject to file 2012-11-08 0

LUDWIG EDWARD J CHAIRMAN

  • Officer
  • Director
No longer subject to file 2012-03-16 0

DURACK DAVID T SENIOR VICE PRESIDENT

  • Officer
14,051 2011-04-28 0

MINEHAN CATHY E.

  • Director
11,535 2011-02-01 0

SHRADER PATRICIA B SENIOR VICE PRESIDENT

  • Officer
0 2010-11-23 0

BRUDER SCOTT P SRVP; CHIEF TECHNOLOGY OFFICER

  • Officer
0 2010-11-23 0

CONSIDINE JOHN R VICE CHAIRMAN

  • Officer
0 2009-11-24 0

OLIYNIK ROBERT G. VICE PRESIDENT AND CONTROLLER

  • Officer
7,028 2009-01-01 0

HANSON ALFRED JOHN EXECUTIVE VICE PRESIDENT

  • Officer
52,578 2008-11-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

BYINGTON CARRIE L - Director

2022-05-10 15:17:59 -0400 2022-05-06 A 107 $255.00 a 215 direct

HICKEY DAVID - Officer EVP & PRESIDENT, LIFE SCIENCES

2022-05-10 15:16:21 -0400 2022-05-06 S 475 $256.00 d 3,806 direct -0.4438 2.463 2.463 6 -0.6637 4

JONES CHRISTOPHER IAN MONTAGUE - Director

2022-05-10 15:14:25 -0400 2022-05-06 A 107 $255.00 a 8,659 direct

NEAL SHANA CAROL - Officer CHIEF HUMAN RESOURCES OFFICER

2022-04-06 10:36:39 -0400 2022-04-06 A 7,525 a 7,599 direct 1.0604 0.1071 -7.2086 1.7624 3 -9.2629 18

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BECTON DICKINSON AND CO BDX 2022-05-20 22:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 21:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 21:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 20:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 20:15:05 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 19:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 19:15:04 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 18:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 18:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 17:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 17:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 16:45:04 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 16:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 15:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 15:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 14:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 14:15:04 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 13:45:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 13:15:03 UTC 0.57 0.25 0
BECTON DICKINSON AND CO BDX 2022-05-20 12:45:03 UTC 0.57 0.25 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund BDX -104.0 shares, $-26022.88 2020-12-31 N-PORT
Ultimus Managers Trust- WAYCROSS LONG/SHORT EQUITY FUND BDX -2600.0 shares, $-631202.0 2020-08-31 N-PORT
FundVantage Trust- Gotham Absolute 500 Core Fund BDX -35.0 shares, $-8041.95 2020-03-31 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund BDX -381.0 shares, $-95333.82 2020-12-31 N-PORT
GLENMEDE FUND INC- Alternative Risk Premia Portfolio BDX -57.0 shares, $-14394.21 2020-04-30 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund BDX -218.0 shares, $-55402.52 2022-01-31 N-PORT
Waycross Independent Trust- WAYCROSS LONG/SHORT EQUITY FUND BDX -3950.0 shares, $-1071556.0 2022-02-28 N-PORT
GLENMEDE FUND INC- Quantitative U.S. Total Market Equity Portfolio BDX -480.0 shares, $-121987.2 2022-01-31 N-PORT
GLENMEDE FUND INC- Quantitative U.S. Long/Short Equity Portfolio BDX -2680.0 shares, $-681095.2 2022-01-31 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund BDX -3362.0 shares, $-845475.76 2021-12-31 N-PORT
FundVantage Trust- Gotham Hedged Core Fund BDX -71.0 shares, $-18886.0 2022-03-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund BDX -58.0 shares, $-15428.0 2022-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund BDX -258.0 shares, $-68628.0 2022-03-31 N-PORT

Elevate your investments